Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about ImCheck Therapeutics aggregated by PharmaCompass.com.

    Client Virtual Booth

    IMCHECK THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    ImCheck Therapeutics
    France Flag
    Country
    Country
    France
    Address
    Address
    31 chemin Joseph Aiguier CS 70071 13402, MARSEILLE Cedex 09
    Telephone
    Telephone
    +33 4 13 96 14 90
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.imchecktherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/imcheck-therapeutics/
    Twitter
    Twitter
    https://twitter.com/ImcheckThx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    ImCheck Presented Positive Data from Phase I/IIa EVICTION-2 Trial of ICT01
    ImCheck Presented Positive Data from Phase I/IIa EVICTION-2 Trial of ICT01

    https://www.globenewswire.com//news-release/2023/11/03/2773393/0/en/ImCheck-Presented-Updated-Positive-Data-from-Phase-I-IIa-EVICTION-2-Trial-of-ICT01-in-Combination-with-Low-dose-IL-2-at-SITC-2023.html

    GLOBENEWSWIRE
    03 Nov 2023
    Share Share
    ImCheck To Present EVICTION-2 Data on ICT01 Combination With Low Dose IL-2
    ImCheck To Present EVICTION-2 Data on ICT01 Combination With Low Dose IL-2

    https://www.globenewswire.com//news-release/2023/10/30/2769008/0/en/ImCheck-To-Present-EVICTION-2-Data-on-ICT01-Combination-With-Low-Dose-IL-2-In-Patients-with-Advanced-Solid-Tumors-at-SITC-Annual-Meeting.html

    GLOBENEWSWIRE
    30 Oct 2023
    Share Share
    ImCheck to Present New Positive Data on ICT01 Monotherapy
    ImCheck to Present New Positive Data on ICT01 Monotherapy

    https://www.globenewswire.com//news-release/2023/10/18/2762717/0/en/Correction-ImCheck-to-Present-New-Positive-Data-on-ICT01-Monotherapy-in-Hematological-Cancers-at-ESMO-2023.html

    GLOBENEWSWIRE
    18 Oct 2023
    Share Share
    ImCheck to Present Positive Data on ICT01 Monotherapy in Hematological Cancers
    ImCheck to Present Positive Data on ICT01 Monotherapy in Hematological Cancers

    https://www.globenewswire.com//news-release/2023/10/15/2760262/0/en/ImCheck-to-Present-New-Positive-Data-on-ICT01-Monotherapy-in-Hematological-Cancers-at-ESMO-2023.html

    GLOBENEWSWIRE
    15 Oct 2023
    Share Share
    ImCheck Achieves the Primary Objectives of PhI of the EVICTION-2 Trial of ICT01
    ImCheck Achieves the Primary Objectives of PhI of the EVICTION-2 Trial of ICT01

    https://www.globenewswire.com/news-release/2023/04/18/2649092/0/en/ImCheck-Achieves-the-Primary-Objectives-of-Phase-I-of-the-EVICTION-2-Trial-of-ICT01-in-Combination-with-Low-Dose-IL-2-Data-Presented-at-AACR-2023.html

    GLOBENEWSWIRE
    18 Apr 2023
    Share Share
    ImCheck Appoints Thomas Civik as Independent Chairman of the Board
    ImCheck Appoints Thomas Civik as Independent Chairman of the Board

    https://www.globenewswire.com/news-release/2023/03/23/2632840/0/en/ImCheck-Appoints-Thomas-Civik-as-Independent-Chairman-of-the-Board.html

    GLOBENEWSWIRE
    23 Mar 2023
    Share Share
    ImCheck To Present Data From EVICTION-2 Study of ICT01 in Combination With IL-2
    ImCheck To Present Data From EVICTION-2 Study of ICT01 in Combination With IL-2

    https://www.globenewswire.com/news-release/2023/03/14/2627267/0/en/ImCheck-To-Present-Data-From-the-EVICTION-2-Study-of-ICT01-in-Combination-With-IL-2-In-Patients-with-Advanced-Solid-Tumors-at-AACR.html

    GLOBENEWSWIRE
    14 Mar 2023
    Share Share
    ImCheck Presents Initial Patient Data from the EVICTION-2 Trial at SITC
    ImCheck Presents Initial Patient Data from the EVICTION-2 Trial at SITC

    https://www.globenewswire.com/news-release/2022/11/11/2554310/0/en/ImCheck-Presents-Initial-Patient-Data-from-the-EVICTION-2-Clinical-Trial-at-SITC-Annual-Meeting.html

    GLOBENEWSWIRE
    11 Nov 2022
    Share Share
    Presents +ve Safety and Efficacy Data from the Completed Ph1 Dose Escalation
    Presents +ve Safety and Efficacy Data from the Completed Ph1 Dose Escalation

    https://www.globenewswire.com/news-release/2022/09/10/2513555/0/en/Presents-Positive-Safety-and-Efficacy-Data-from-the-Completed-Phase-1-Dose-Escalation-Cohort-of-ICT01-plus-Pembrolizumab-in-the-EVICTION-Trial-at-ESMO-Congress-2022.html

    GLOBENEWSWIRE
    10 Sep 2022
    Share Share
    ImCheck Closes Upsized EUR 96M Financing to Advance Clinical Program
    ImCheck Closes Upsized EUR 96M Financing to Advance Clinical Program

    https://www.globenewswire.com/news-release/2022/06/13/2460832/0/en/ImCheck-Closes-Upsized-EUR-96-Million-USD-103-Million-Financing-to-Advance-Clinical-Program-of-First-in-human-Gamma-delta-T-Cell-Activating-Antibody-and-Accelerate-Development-of-D.html

    GLOBENEWSWIRE
    13 Jun 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search